Sixfold Bioscience

Active

Delivering RNA therapies.

Winter 2018Founded 201827 peopleLondon, England, United Kingdom

www.sixfold.bio ↗LinkedIn ↗X ↗Crunchbase ↗See on the Idea Map Healthcare momentum

About

Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.

From their website

as of Jun 7, 2026www.sixfold.bio ↗

Biotech/Health

Sixfold Bioscience develops a platform focused on delivering RNA therapies. The company aims to solve RNA delivery, leveraging AI-inspired methods to advance the field.

Sixfold offers the Mergo® Platform, designed to enable delivery of RNA therapies. The platform emphasizes evolution-inspired approaches and AI-assisted development to improve delivery performance for RNA-based treatments.

Who it’s for: Biotech/health organizations developing RNA therapies, including pharmaceutical companies and research institutions pursuing RNA delivery solutions.

Features